These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 19440066)
41. Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ata Y; Turk T; Ay D; Eris C; Demir M; Ari H; Ata F; Yavuz S; Ozyazicioglu A Heart Surg Forum; 2009 Aug; 12(4):E211-6. PubMed ID: 19683991 [TBL] [Abstract][Full Text] [Related]
42. Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke. Jensen JK; Atar D; Kristensen SR; Mickley H; Januzzi JL Am J Cardiol; 2009 Jul; 104(2):287-91. PubMed ID: 19576362 [TBL] [Abstract][Full Text] [Related]
43. Heart failure biomarkers and prediction of early left ventricle remodeling after acute coronary syndromes. Cordero A; Velasco I; Flores E; López-Ayala JM; Sánchez-Munuera S; Muñoz-Villalba MP; Selva-Mora A; Galán-Giménez F; de la Espriella R; Nuñez J Clin Biochem; 2024 Oct; 131-132():110814. PubMed ID: 39218335 [TBL] [Abstract][Full Text] [Related]
44. Effects of hemoglobin concentration and creatinine clearance in pro-B-type natriuretic peptide-based left ventricular filling pressure prediction in patients with preserved left ventricular systolic function. Choi EY; Ha JW; Joung B; Ko YG; Choi D; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY Am J Cardiol; 2008 Feb; 101(3):364-9. PubMed ID: 18237601 [TBL] [Abstract][Full Text] [Related]
45. Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure. Núñez J; Sanchis J; Bodí V; Fonarow GC; Núñez E; Bertomeu-González V; Miñana G; Consuegra L; Bosch MJ; Carratalá A; Chorro FJ; Llàcer A Eur Heart J; 2010 Jul; 31(14):1752-63. PubMed ID: 20501480 [TBL] [Abstract][Full Text] [Related]
46. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure. Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067 [TBL] [Abstract][Full Text] [Related]
48. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation. Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135 [TBL] [Abstract][Full Text] [Related]
49. Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome. LeLeiko RM; Vaccari CS; Sola S; Merchant N; Nagamia SH; Thoenes M; Khan BV Am J Cardiol; 2009 Sep; 104(5):638-43. PubMed ID: 19699337 [TBL] [Abstract][Full Text] [Related]
50. Could BNP screening of acute chest pain cases lead to safe earlier discharge of patients with non-cardiac causes? A pilot study. Brown A; George J; Murphy MJ; Struthers A QJM; 2007 Dec; 100(12):755-61. PubMed ID: 18089541 [TBL] [Abstract][Full Text] [Related]
51. The role of adrenomedullin and brain natriuretic peptide levels in acute rheumatic fever in adults. Bayram E; Kocatürk H; Yücel O; Atalay C; Colak MC; Ateşal S Anadolu Kardiyol Derg; 2008 Jun; 8(3):188-91. PubMed ID: 18524724 [TBL] [Abstract][Full Text] [Related]
57. [Value of biochemical marker detection in risk stratification in patients with acute coronary syndrome]. Liu B; Fu Q; Yan QN; Jin W; Tao DP; Hua JH; Li ZL Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1015-9. PubMed ID: 20501382 [TBL] [Abstract][Full Text] [Related]
58. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide]. Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693 [TBL] [Abstract][Full Text] [Related]
59. CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure. Vizzardi E; Nodari S; D'Aloia A; Chiari E; Faggiano P; Metra M; Dei Cas L Echocardiography; 2008 Oct; 25(9):955-60. PubMed ID: 18771557 [TBL] [Abstract][Full Text] [Related]